深度学习级联模型在近红外自体荧光甲状旁腺识别中应用研究

石锦杨, 林炫, 王思思, 黄文煜, 何绍峰, 唐子涵, 林梦婷, 陈飞, 赵文新, 王波

中国实用外科杂志 ›› 2025, Vol. 45 ›› Issue (12) : 1422-1429.

PDF(3867 KB)
PDF(3867 KB)
中国实用外科杂志 ›› 2025, Vol. 45 ›› Issue (12) : 1422-1429. DOI: 10.19538/j.cjps.issn1005-2208.2025.12.15
论著

深度学习级联模型在近红外自体荧光甲状旁腺识别中应用研究

作者信息 +

Application of a deep-learning cascade model for near-infrared autofluorescence parathyroid identification

Author information +
文章历史 +

摘要

目的 评价一种基于深度学习的两阶段近红外自体荧光(NIRAF)甲状旁腺识别模型在提高手术中甲状旁腺识别准确性方面的效果,并验证其在降低假阳性率和提供解剖学定位参考中的应用价值。方法 前瞻性纳入福建医科大学附属协和医院2023年1月至2023年12月期间接受甲状腺切除术的101例病人。术后在标准手术间灯光下、固定距离15 cm处使用785 nm激光近红外相机采集新鲜标本NIRAF影像,共获得30 122帧图像,构建Niraf24数据集。模型由YOLOv8x检测网络和Segment Anything Model v2(SAM2)分割网络组成,前者用于荧光信号定位,后者用于甲状腺轮廓分割及背景恢复。通过灵敏度(sensitivity)、精确率(precision)、F1值、假阳性率及交并比(IoU)等指标评价模型性能,并与传统荧光直读法比较。结果 两阶段模型显著降低了假阳性比例,帧水平由37.7%降至13.2%,标本水平由38.8%降至6.7%(均P<0.001),精确率由62.3%升至86.8%,F1值由0.734升至0.846,灵敏度保持在82.8%。SAM2生成的甲状腺轮廓平均交并比为(0.985±0.012),显示其解剖定位高度一致。模型在高噪声环境(棕色脂肪、热凝痂、弥漫性高荧光背景、手术染料污染等)下依然保持稳定性能,显著抑制困难假阳性信号。在不降低灵敏度的前提下,两阶段级联相较传统判读显著降低假阳性并提升整体效能,验证了“先检后分”的任务适配性与术中应用可行性。结论 基于YOLOv8-SAM2的两阶段深度学习级联模型在不降低灵敏度的前提下显著提高了NIRAF的特异性,能够实时生成具有解剖学参照意义的可视化信息,为甲状旁腺保护提供技术支持。该方法建立了可重复的性能基准,为多中心临床验证和术中智能决策提供了新的思路,有助于减少甲状旁腺误切与术后低钙血症的发生。

Abstract

Objective To assess the effectiveness of a two-stage deep-learning near-infrared autofluorescence (NIRAF) model for improving intraoperative parathyroid identification accuracy and to validate its utility in reducing false-positive rates and providing anatomical localization reference. Methods A total of 101 patients undergoing thyroidectomy at Fujian Medical University Union Hospital from January 2023 to December 2023 were prospectively enrolled. Under standard operating-room lighting at a fixed distance of 15 cm, a 785-nm laser NIR camera was used to acquire NIRAF images from fresh specimens’ post-resection, yielding 30,122 frames to construct the “Niraf24” dataset. The model consisted of a YOLOv8x detection network for fluorescence-signal localization and a Segment Anything Model v2 (SAM2) segmentation network for thyroid contour segmentation and background restoration. Performance was evaluated using sensitivity, precision, F1-score, false-positive rate, and intersection over union (IoU), and compared with conventional direct fluorescence reading. Results The two-stage model markedly reduced false positives: frame-level from 37.7% to 13.2% and specimen-level from 38.8% to 6.7% (both P<0.001). Precision increased from 62.3% to 86.8%, F1-score improved from 0.734 to 0.846, while sensitivity was maintained at 82.8%. The SAM2-derived thyroid contours achieved a mean IoU of (0.985±0.012), indicating highly consistent anatomical localization. The model remained robust in high-noise settings (brown adipose tissue, thermal coagulation eschar, diffuse high-fluorescence background, surgical dye contamination), effectively suppressing difficult false-positive signals. Without compromising sensitivity, the two-stage cascade approach markedly reduced false positives and improved overall performance compared to conventional interpretation methods, validating the task suitability of the “detection-first, classification-second” strategy and its feasibility for intraoperative application. Conclusion The YOLOv8-SAM2-based two-stage deep-learning cascade significantly enhances the specificity of NIRAF without compromising sensitivity, generating real-time, anatomically referenced visual information to support parathyroid preservation. This approach establishes a reproducible performance benchmark and offers a new paradigm for multicenter clinical validation and intraoperative intelligent decision-making, with the potential to reduce inadvertent parathyroidectomy and postoperative hypocalcemia.

关键词

甲状旁腺 / 近红外自体荧光 / 深度学习 / 甲状腺切除术 / 手术决策支持 / 人工智能

Key words

parathyroid gland / near-infrared autofluorescence / deep learning / thyroidectomy / surgical decision support / artificial intelligence

引用本文

导出引用
石锦杨, 林炫, 王思思, . 深度学习级联模型在近红外自体荧光甲状旁腺识别中应用研究[J]. 中国实用外科杂志. 2025, 45(12): 1422-1429 https://doi.org/10.19538/j.cjps.issn1005-2208.2025.12.15
SHI Jin-yang, LIN Xuan, WANG Si-si, et al. Application of a deep-learning cascade model for near-infrared autofluorescence parathyroid identification[J]. Chinese Journal of Practical Surgery. 2025, 45(12): 1422-1429 https://doi.org/10.19538/j.cjps.issn1005-2208.2025.12.15
中图分类号: R6   

参考文献

[1]
Wang B, Zheng J, Yu JF, et al. Development of artificial intelligence for parathyroid recognition during endoscopic thyroid surgery[J]. Laryngoscope, 2022, 132(12): 2516-2523. DOI: 10.1002/lary.30173.
We aimed to establish an artificial intelligence (AI) model to identify parathyroid glands during endoscopic approaches and compare it with senior and junior surgeons' visual estimation.
[2]
Radakrishnan A, Reddy AT, Dalal P, et al. Hypocalcemia prevention and management after thyroidectomy in children: a systematic review[J]. J Pediatr Surg, 2021, 56(3): 526-533. DOI: 10.1016/j.jpedsurg.2020.08.032.
Hypocalcemia is the most common complication following thyroidectomy in children. Guidelines to manage post-thyroidectomy hypocalcemia are available for adults, but not children. The objective of this review was to identify practices related to hypocalcemia prevention and management in pediatric patients.We identified studies examining the prevention and management of hypocalcemia in pediatric patients post-thyroidectomy within PubMed, EMBASE, Web of Science and Cochrane databases. Three independent reviewers screened citations and reviewed full-text papers.A total of 15 studies were included, representing 1552 patients. The overall study quality was weak with lack of randomization and inconsistent outcome reporting. The pooled incidence of hypocalcemia from the 15 studies was 35.5% for transient hypocalcemia and 4.2% for permanent hypocalcemia. All studies discussed post-operative hypocalcemia treatment, with most patients requiring admission for intra-venous calcium therapy. One study described a protocol discharging asymptomatic patients on calcitriol and calcium. Three studies discussed preoperative calcium supplementation in patients at risk of hypocalcemia. No studies examined routine use of calcium and/or vitamin D supplementation to prevent post-operative hypocalcemia.A significant number of children undergoing thyroidectomy develop hypocalcemia. Despite this high incidence, our systematic review demonstrates significant practice variation surrounding post-thyroidectomy hypocalcemia prevention and management in children.III (systematic review of studies of which some were case-control studies (III) and some were case series (IV)).Copyright © 2020 Elsevier Inc. All rights reserved.
[3]
Alqahtani SM, Alatawi AS, Alalawi YS. Post-thyroidectomy hypocalcemia: a single-center experience[J]. Cureus, 2021, 13(11): e20006. DOI: 10.7759/cureus.20006.
[4]
田文, 王冰. 甲状腺癌根治术关键技术标准及评价[J]. 中国实用外科杂志, 2024, 44(1): 38-42. DOI: 10.19538/j.cjps.issn1005-2208.2024.01.04.
[5]
Marian D, Scurtu GA, Fülöp RL, et al. Incidental parathyroidectomy is a frequent complication of thyroid surgery: a retrospective study of 3065 patients[J]. Ann Ital Chir, 2023, 94(3): 240-244.
[6]
Cottrill EE. Avoiding complications of thyroidectomy: preservation of parathyroid glands[J]. Otolaryngol Clin North Am, 2024, 57(1): 63-74. DOI: 10.1016/j.otc.2023.09.002.
[7]
Canali L, Russell MD, Sistovaris A, et al. Camera-based near-infrared autofluorescence versus visual identification in total thyroidectomy for parathyroid function preservation: systematic review and meta-analysis of randomized clinical trials[J]. Head Neck, 2025, 47(1): 225-234. DOI: 10.1002/hed.27900.
Hypocalcemia is the most common postoperative complication of total thyroidectomy. Near‐infrared autofluorescence (NIRAF) technology is a surgical adjunct that has been increasingly utilized with the aim of preventing postoperative hypocalcemia, but its clinical benefits have not yet been firmly established. The aim of this study was to assess the clinical benefit of utilizing NIRAF technology in patients undergoing total thyroidectomy.
[8]
Paras C, Keller M, White L, et al. Near-infrared autofluorescence for the detection of parathyroid glands[J]. J Biomed Opt, 2011, 16(6): 067012. DOI: 10.1117/1.3583571.
[9]
Wang B, Zhou CP, Ao W, et al. Exploring near-infrared autofluorescence properties in parathyroid tissue: an analysis of fresh and paraffin-embedded thyroidectomy specimens[J]. J Biomed Opt, 2025, 30(suppl): 13702. DOI: 10.1117/1.JBO.30.S1.S13702.
[10]
Wang B, Yu JF, Lin SY, et al. Intraoperative AI-assisted early prediction of parathyroid and ischemia alert in endoscopic thyroid surgery[J]. Head Neck, 2024, 46(8): 1975-1987. DOI: 10.1002/hed.27629.
The preservation of parathyroid glands is crucial in endoscopic thyroid surgery to prevent hypocalcemia and related complications. However, current methods for identifying and protecting these glands have limitations. We propose a novel technique that has the potential to improve the safety and efficacy of endoscopic thyroid surgery.
[11]
花苏榕, 廖泉. 甲状腺癌术后复发再手术中甲状旁腺和神经保护[J]. 中国实用外科杂志, 2021, 41(8): 871-874. DOI: 10.19538/j.cjps.issn1005-2208.2021.08.08.
[12]
Russell BC, Torralba A, Murphy KP, et al. LabelMe: a database and web-based tool for image annotation[J]. Int J Comput Vis, 2008, 77(1): 157-173. DOI: 10.1007/s11263-007-0090-8.
[13]
Akgun E, Ibrahimli A, Berber E. Near-infrared autofluorescence signature: a new parameter for intraoperative assessment of parathyroid glands in primary hyperparathyroidism[J]. J Am Coll Surg, 2025, 240(1): 84-93. DOI: 10.1097/XCS.0000000000001147.
The success of parathyroidectomy in primary hyperparathyroidism depends on the intraoperative differentiation of diseased from normal glands. Deep learning can potentially be applied to digitalize this subjective interpretation process that relies heavily on surgeon expertise. In this study, we aimed to investigate whether diseased vs normal parathyroid glands have different near-infrared autofluorescence (NIRAF) signatures and whether related deep learning models can predict normal vs diseased parathyroid glands based on intraoperative in vivo images.
[14]
Akgun E, Uysal M, Avci SN, et al. The use of artificial intelligence to detect parathyroid tissue on ex vivo specimens during thyroidectomy and parathyroidectomy procedures using near-infrared autofluorescence signals[J]. Surgery, 2024, 176(5): 1396-1401. DOI: 10.1016/j.surg.2024.07.015.
[15]
Yu F, Sang T, Kang J, et al. An automatic parathyroid recognition and segmentation model based on deep learning of near-infrared autofluorescence imaging[J]. Cancer Med, 2024, 13(4): e7065. DOI: 10.1002/cam4.7065.
Near‐infrared autofluorescence imaging (NIFI) can be used to identify parathyroid gland (PG) during surgery. The purpose of the study is to establish a new model, help surgeons better identify, and protect PGs.
[16]
Kim DH, Kim SW, Kang P, et al. Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patients undergoing total thyroidectomy and central neck dissection[J]. Thyroid, 2021, 31(9): 1400-1408. DOI: 10.1089/thy.2020.0970.
Near-infrared autofluorescence (NIRAF) imaging is known to reduce the incidence of post-thyroidectomy hypocalcemia. However, there are no studies on how much NIRAF imaging affects the serum parathyroid hormone (PTH) level after surgery. We investigated the changes of the serum PTH level and ionized calcium (iCa.) in patients undergoing total thyroidectomy with central neck dissection (CND).This retrospective study with historical control enrolled 542 patients who underwent total thyroidectomy with CND. Patients were divided into two groups: the NIRAF group (261 patients) and the control group (281 patients). PTH and iCa. level were measured at the hospital stay, 1 month, 3 months, and 6 months after surgery. In addition, the number of identified parathyroid glands (PGs), auto-transplanted PGs, and the inadvertent resection rate of PGs were evaluated.The incidence of postoperative hypoparathyroidism (PTH < 15pg/mL) was significantly lower in the NIRAF group during the hospitalization (88 patients: 33.7% vs. 131 patients : 46.6%; p = 0.002) and at 1 month postoperatively (23 patients : 8.8% vs. 53 patients : 18.9%; p = 0.001). There was no difference in the permanent hypoparathyroidism rate (6 months after surgery) between the NIRAF group and the control group (4.2% vs. 4.6%; p = 0.816). There was no difference in the incidence of hypocalcemia (iCa. < 1.09mmol/L) (during hospitalization: 6.5% vs. 10.0%, 1 month : 2.3% vs. 2.5%, 3 months : 0.8% vs. 0.7%, 6 months after surgery; 1.1% vs. 1.1% ) between the two groups. The number of inadvertently resected PGs was significantly lower in the NIRAF group (18:6.9% vs. 36:12.8%; p = 0.021).These results suggest that NIRAF imaging may reduce temporary hypoparathyroidism and the risk of inadvertent resection of PGs in patients undergoing total thyroidectomy with CND.
[17]
Sehnem L, Noureldine SI, Avci S, et al. A multicenter evaluation of near-infrared autofluorescence imaging of parathyroid glands in thyroid and parathyroid surgery[J]. Surgery, 2023, 173(1): 132-137. DOI: 10.1016/j.surg.2022.07.057.
[18]
Rao KN, Rajguru R, Dange P, et al. Lower rates of hypocalcemia following near-infrared autofluorescence use in thyroidectomy: a meta-analysis of RCTs[J]. Diagnostics (Basel), 2024, 14(5): 505. DOI: 10.3390/diagnostics14050505.
[19]
陈志达, 郗洪庆, 刘培发, 等. 近红外自体荧光显像技术在甲状腺肿瘤手术中辅助识别甲状旁腺有效性分析[J]. 中国实用外科杂志, 2021, 41(8): 882-885. DOI: 10.19538/j.cjps.issn1005-2208.2021.08.11.
[20]
Solórzano CC, Thomas G, Berber E, et al. Current state of intraoperative use of near infrared fluorescence for parathyroid identification and preservation[J]. Surgery, 2021, 169(4): 868-878. DOI: 10.1016/j.surg.2020.09.014.
[21]
Silver Karcioglu AL, Triponez F, Solórzano CC, et al. Emerging imaging technologies for parathyroid gland identification and vascular assessment in thyroid surgery: a review from the American Head and Neck Society Endocrine Surgery Section[J]. JAMA Otolaryngol Head Neck Surg, 2023, 149(3): 253-260. DOI: 10.1001/jamaoto.2022.4421.
Identification and preservation of parathyroid glands (PGs) remain challenging despite advances in surgical techniques. Considerable morbidity and even mortality result from hypoparathyroidism caused by devascularization or inadvertent removal of PGs. Emerging imaging technologies hold promise to improve identification and preservation of PGs during thyroid surgery.
[22]
Toro-Tobon D, Loor-Torres R, Duran M, et al. Artificial intelligence in thyroidology: a narrative review of the current applications, associated challenges, and future directions[J]. Thyroid, 2023, 33(8): 903-917. DOI: 10.1089/thy.2023.0132.
The use of Artificial intelligence (AI) in healthcare has grown exponentially with the promise of facilitating biomedical research and enhancing diagnosis, treatment, monitoring, disease prevention and healthcare delivery. We aim to examine the current state, limitations, and future directions of AI in thyroidology.AI has been explored in thyroidology since the 1990s, and currently, there is an increasing interest in applying AI to improve the care of patients with thyroid nodules, thyroid cancer, and functional or autoimmune thyroid disease. These applications aim to automate processes, improve the accuracy and consistency of diagnosis, personalize treatment, decrease the burden for healthcare professionals, improve access to specialized care in areas lacking expertise, deepen the understanding of subtle pathophysiologic patterns, and accelerate the learning curve of less experienced clinicians. There are promising results for many of these applications. Yet, most are in the validation or early clinical evaluation stages. Only a few are currently adopted for risk stratification of thyroid nodules by ultrasound and determination of the malignant nature of indeterminate thyroid nodules by molecular testing. Challenges of the currently available AI applications include the lack of prospective and multicenter validations and utility studies, small and low diversity of training datasets, differences in data sources, lack of explainability, unclear clinical impact, inadequate stakeholder engagement, and inability to use outside of the research setting which might limit the value of their future adoption.AI has the potential to improve many aspects of thyroidology; however, addressing the limitations affecting the suitability of AI interventions in thyroidology is a prerequisite to ensure AI provides added value for patients with thyroid disease.

基金

福建省财政科研项目(2023CZ008)
福建省甲状腺癌精准管理临床研究中心项目(2022Y2006)
福建省甲状腺癌精准管理临床研究中心项目(2024YGPT003)
福建省科技创新联合基金项目(2023Y9135)
福建省科技创新联合基金项目(2023Y9190)
福建省科技创新联合基金项目(2023Y9119)
福建省教育厅研究生教育教学研究项目(YT25002)

PDF(3867 KB)

Accesses

Citation

Detail

段落导航
相关文章

/